Condition: Morning Sickness · Sponsor: Duchesnay Inc.
The primary objective of this study is to compare the efficacy of Diclegis for the treatment of nausea and vomiting of pregnancy (NVP) in pregnant adolescents aged 12 to 17 years with placebo. The secondary objective of this study is to compare the safety of Diclegis in pregnant adolescents aged 12 to 17 years with placebo by assessing differences in the severity and occurrence of maternal adverse events (AEs).
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Watching Over Mothers and Babies | Tucson, Arizona, United States | — |
| Clinica Del Socorro Medical Group, Inc. | Los Angeles, California, United States | — |
| Futura Research | Norwalk, California, United States | — |
| Medical Professional CR Center | Miami, Florida, United States | — |
| Empire Clinical Research, LLC | Miami Lakes, Florida, United States | — |
| Western Michigan University Homer Stryker M.D. School of Medicine | Kalamazoo, Michigan, United States | — |
| Jersey Shore University Medical Center | Neptune City, New Jersey, United States | — |
| Complete Healthcare for Women | Columbus, Ohio, United States | — |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02045901